- Glaukos Corporation Announces Second Quarter 2022 Financial Results
- Glaukos Announces FDA 510(k) Clearance of iStent infinite®
- Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3
- Glaukos Announces Participation in the William Blair Growth Stock Conference
- Chau Khuong Joins Catalio Capital Management as General Partner
- Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology Symposium
More ▼
Key statistics
On Monday, Glaukos Corp (GKOS:NYQ) closed at 52.73, -18.24% below its 52-week high of 64.49, set on Apr 08, 2022.
52-week range
Markit short selling activity
Open | 49.80 |
---|---|
High | 53.12 |
Low | 49.80 |
Bid | 39.99 |
Offer | 61.00 |
Previous close | 50.38 |
Average volume | 641.95k |
---|---|
Shares outstanding | 47.60m |
Free float | 45.73m |
P/E (TTM) | -- |
Market cap | 2.40bn USD |
EPS (TTM) | -1.19 USD |
Data delayed at least 15 minutes, as of Aug 15 2022 21:10 BST.
More ▼